Also, a recent study demonstrated that by increasing SMC death and enhancing SMC inflammation, SMC‐specific ATG5 deficiency promoted the progression of AAA formation in angiotensin II‐treated mice with transforming growth factor‐β (TGF‐β) inhibition (Clement et al., 2019). The gene discussed is ATG5; the disease is triple-A syndrome.